GT200900172A - Acetofenonas sustituidas utiles en terapia. - Google Patents

Acetofenonas sustituidas utiles en terapia.

Info

Publication number
GT200900172A
GT200900172A GT200900172A GT200900172A GT200900172A GT 200900172 A GT200900172 A GT 200900172A GT 200900172 A GT200900172 A GT 200900172A GT 200900172 A GT200900172 A GT 200900172A GT 200900172 A GT200900172 A GT 200900172A
Authority
GT
Guatemala
Prior art keywords
represent
independently
acetophenons
therapy
haloalkyl
Prior art date
Application number
GT200900172A
Other languages
English (en)
Inventor
Jakob Felding
Simon Feldbaek Nielsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200900172A publication Critical patent/GT200900172A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENVCIÓN EPRESENTA COMPUESTOS DERIVADOS DE ACETOFENONAS SUSTITUIDAS, PROCESOS PARA LA PREPARACIÓN DE DICHOS COMPUESTOS; CON DICHOS COMPUESTOS PARA EL USO EN TERAPIA; COMPOSICIONES FARMACÉUTICAS QUE COMPRENDAN DICHOS COMPUESTOS; CON MÉTODOS PARA EL TRATAMIENTO DE ENFERMEDADES, POR EJEMPLO, ENFERMEDADES DERMATOLÓGICAS, CON DICHOS COMPUESTOS, Y CON EL USO DE DICHOS COMPUESTOS EN LA ELABORACIÓN DE MEDICAMENTOS.
GT200900172A 2006-12-22 2009-06-19 Acetofenonas sustituidas utiles en terapia. GT200900172A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87168906P 2006-12-22 2006-12-22
US94547007P 2007-06-21 2007-06-21

Publications (1)

Publication Number Publication Date
GT200900172A true GT200900172A (es) 2011-10-05

Family

ID=39156588

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200900172A GT200900172A (es) 2006-12-22 2009-06-19 Acetofenonas sustituidas utiles en terapia.

Country Status (24)

Country Link
US (3) US8148537B2 (es)
EP (1) EP2125736B1 (es)
JP (1) JP5342451B2 (es)
KR (1) KR101507717B1 (es)
AT (1) ATE503742T1 (es)
AU (1) AU2007336538B2 (es)
BR (1) BRPI0721113A2 (es)
CA (1) CA2673370C (es)
CR (1) CR10877A (es)
CY (1) CY1111596T1 (es)
DE (1) DE602007013617D1 (es)
DK (1) DK2125736T3 (es)
GT (1) GT200900172A (es)
HK (1) HK1135392A1 (es)
HR (1) HRP20110464T1 (es)
IL (1) IL199383A (es)
MX (1) MX2009006593A (es)
MY (1) MY146022A (es)
NO (1) NO20092372L (es)
NZ (1) NZ577863A (es)
PL (1) PL2125736T3 (es)
PT (1) PT2125736E (es)
RU (1) RU2493149C2 (es)
WO (1) WO2008077404A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010335655B2 (en) 2009-12-22 2015-03-05 Leo Pharma A/S Calcipotriol monohydrate nanocrystals
EP2515866B1 (en) 2009-12-22 2014-02-19 Leo Pharma A/S Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
CN102781425B (zh) 2009-12-22 2014-08-13 利奥制药有限公司 含有维生素d类似物以及溶剂和表面活性剂混合物的皮肤用组合物
CN102775345A (zh) * 2011-05-13 2012-11-14 上海特化医药科技有限公司 制备罗氟司特的方法及中间体
CN104822392B (zh) * 2012-11-30 2017-09-08 利奥制药有限公司 抑制活化的t‑细胞中il‑22表达的方法
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
CN114621139A (zh) 2013-10-22 2022-06-14 奇斯药制品公司 用于制备pde4抑制剂的方法
JP6785666B2 (ja) * 2014-06-23 2020-11-18 レオ ファーマ アクティーゼルスカブ １，３−ベンゾジオキソール複素環化合物の調製方法
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
CA3007432A1 (en) 2015-12-18 2017-06-22 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
KR101702648B1 (ko) * 2016-05-10 2017-02-03 주식회사 엑티브온 피부 외용제용 보존제, 이를 포함하는 화장료 조성물 및 약학 조성물
KR102676384B1 (ko) 2017-06-20 2024-06-20 유니온 테라퓨틱스 에이/에스 1,3-벤조디옥솔 헤테로시클릭 화합물의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (es) * 1992-12-23 1995-11-21 Celltech Ltd
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
PT771794E (pt) * 1995-05-19 2006-09-29 Kyowa Hakko Kogyo Kk Compostos heterociclicos contendo oxigenio
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
AU4967697A (en) * 1996-11-19 1998-06-10 Kyowa Hakko Kogyo Co. Ltd. Oxygenic heterocyclic compounds
WO2004082683A1 (ja) * 2003-03-17 2004-09-30 Kyowa Hakko Kogyo Co., Ltd. 慢性皮膚疾患の治療および／または予防剤
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
US20070049611A1 (en) * 2005-06-10 2007-03-01 Talamas Francisco X Phosphodiesterase 4 inhibitors

Also Published As

Publication number Publication date
US20100035908A1 (en) 2010-02-11
CR10877A (es) 2009-07-10
MY146022A (en) 2012-06-15
EP2125736B1 (en) 2011-03-30
RU2009128191A (ru) 2011-01-27
NO20092372L (no) 2009-07-14
PL2125736T3 (pl) 2011-09-30
BRPI0721113A2 (pt) 2014-10-07
KR20090098990A (ko) 2009-09-18
US20120165539A1 (en) 2012-06-28
EP2125736A1 (en) 2009-12-02
DK2125736T3 (da) 2011-07-11
US8324394B2 (en) 2012-12-04
RU2493149C2 (ru) 2013-09-20
KR101507717B1 (ko) 2015-04-08
US8497380B2 (en) 2013-07-30
CA2673370A1 (en) 2008-07-03
AU2007336538A1 (en) 2008-07-03
JP2010513334A (ja) 2010-04-30
HK1135392A1 (en) 2010-06-04
JP5342451B2 (ja) 2013-11-13
PT2125736E (pt) 2011-07-01
US20130012716A1 (en) 2013-01-10
NZ577863A (en) 2012-04-27
US8148537B2 (en) 2012-04-03
MX2009006593A (es) 2009-07-02
ATE503742T1 (de) 2011-04-15
HRP20110464T1 (hr) 2011-07-31
WO2008077404A1 (en) 2008-07-03
CA2673370C (en) 2015-11-17
IL199383A (en) 2015-02-26
AU2007336538B2 (en) 2012-04-05
DE602007013617D1 (de) 2011-05-12
CY1111596T1 (el) 2015-10-07

Similar Documents

Publication Publication Date Title
CR10877A (es) Acetofenonas sustituidas utiles en terapia
UA115666C2 (uk) Заміщена оксимом амідна сполука і засіб для боротьби зі шкідниками
WO2007071632A3 (en) 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases
NO20063129L (no) Substituerte 6-cykloheksylalkylsubstituerte 2-kinolinoner og 2-kinoksalinoner som poly(ADP-ribose) polymeraseinhibitorer
WO2003024967A3 (en) Indolizines as kinase protein inhibitors
NO20063028L (no) 6-substituerte 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
MX2009005449A (es) Compuesto heteromonociclico y uso del mismo.
PE20150767A1 (es) Inhibidores de gdf-8
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
HUP0400828A2 (hu) Kondenzált heterociklikus aminopirimidinek, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
MXPA05009359A (es) Tetrahidroisoquinolinas 2,5- y 2,6 substituidas para uso como moduladores 5-ht6.
TW200744604A (en) P38 MAP kinase inhibitors and methods for using the same
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
NO20071719L (no) Pyridylinhibitorer for "hedgehog"-signalisering
CR8744A (es) Compuestos terapeuticos
TW200700066A (en) Compounds for inhibiting ksp kinesin activity
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
EA200701780A1 (ru) Противоопухолевое средство
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
TW200719894A (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives
TW200716571A (en) Heterocyclic reverse transcriptase inhibitors
MY136824A (en) Substituted benzoxazinones and uses thereof
UA96783C2 (ru) Замещенные метилфенилкетоны, пригодные для использования как ингибиторы pde4
MXPA04007048A (es) Derivados de amidoacetonitrilo.